OxRML/AgentSLR huggingface dataset:
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 0 Percentage (%) (Mean)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 0 / 494 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Mixed groups, sex: Both, ages 1 to 86
Country: Iran
Location: Hormozgan province
Setting: Mixed settings, Both urban and rural areas
Sample size: 494
Study period: Sep 2016 - Jun 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 0.1 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 0 - 0.5 (95% CI)
Numerator/denominator: 1 / 31 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Children, sex: Unspecified, ages 0.5 to 5
Country: DRC
Setting: Population based, Unspecified
Study period: 2013 - 2014
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 3.5 Percentage (%) (Unspecified)
Exponent (base 10): 0
Numerator/denominator: 34 / 978 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Children, sex: Unspecified, ages 0.5 to 5
Country: DRC
Setting: Population based, Unspecified
Sample size: 978
Study period: 2013 - 2014
Parameter: Reproduction number (Basic R0) - Vector-borne (Reproduction number)
Value: 2.475 No units (Mean)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Animal-animal
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Setting: Population based, Unspecified
Study period: 6 Feb 2016 - 2 Jun 2016
Parameter: Reproduction number (Basic R0) - Sexual (Reproduction number)
Value: 0.0538 No units (Mean)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Human-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Setting: Population based, Unspecified
Study period: 6 Feb 2016 - 2 Jun 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.502 No units (Mean)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Setting: Population based, Unspecified
Study period: 6 Feb 2016 - 2 Jun 2016
Parameter: Growth rate (r) (Growth rate)
Value: 0.823 Per week (Maximum likelihood)
Exponent (base 10): 0
Uncertainty: 0.053 (Standard Deviation)
Uncertainty (single): 0.053 (Standard Deviation)
Statistical approach: Estimated model parameter
Reproduction number method: Growth rate Vector-human
Country: Brazil
Location: Rio de Janeiro
Study period: 18 Oct 2015 - Unspecified
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.33 No units (Maximum likelihood)
Exponent (base 10): 0
Uncertainty: 1.97 - 2.97 (95% CI)
Statistical approach: Estimated model parameter
Disaggregated by: Other, Region
Reproduction number method: Growth rate Vector-human
Country: Multi-country: Brazil and Colombia
Location: Rio de Janeiro
Study period: 18 Oct 2015 - Unspecified
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value:  No units (Unspecified)
Exponent (base 10): 0
Bounds: 1.24 - 1.47
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Compartmental model Other
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: United States
Location: Florida
Setting: Population based, Unspecified
Study period: 19 Jul 2016 - 29 Sep 2016
Parameter: Human delay - infectious period (inverse parameter) (Human delay)
Value:  Per day (Unspecified)
Exponent (base 10): 0
Bounds: 0.02 - 0.1
Statistical approach: Estimated model parameter
Disaggregated by: Method, Other
Reproduction number method: Compartmental model 
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: United States
Location: Florida
Setting: Population based, Unspecified
Study period: 19 Jul 2016 - 29 Sep 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 3.8 No units (Mean)
Exponent (base 10): 0
Uncertainty: 2.4 - 5.6 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Other
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Colombia
Location: Barranquilla
Setting: Hospital based, Urban area
Sample size: 359
Study period: 1 Oct 2015 - Nov 2015
Parameter: Relative contribution - sexual (Relative contribution)
Value: 23 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 0.01 - 0.47 (95% CI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Colombia
Location: Barranquilla
Setting: Hospital based, Urban area
Sample size: 359
Study period: 1 Oct 2015 - Nov 2015
Parameter: Growth rate (r) (Growth rate)
Value: 0.076 Per day (Unspecified)
Exponent (base 10): 0
Uncertainty: 0.066 - 0.087 (95% CI)
Bounds: 0.071 - 0.111
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Colombia
Location: Barranquilla
Setting: Hospital based, Urban area
Sample size: 359
Study period: 1 Oct 2015 - Nov 2015
Parameter: Human delay - latent period (inverse parameter) (Human delay)
Value: 0.04 No units (Maximum likelihood)
Exponent (base 10): 0
Uncertainty: 0.02 - 0.07 (Other)
Statistical approach: Estimated model parameter
Population: Unspecified, sex: Unspecified, ages  to 
Country: Colombia
Setting: Unspecified, Unspecified
Study period: 2015 - 2016
Parameter: Mosquito delay - extrinsic incubation period (inverse parameter) (Mosquito)
Value: 0.0038 No units (Maximum likelihood)
Exponent (base 10): 0
Uncertainty: 0.0013 - 0.0144 (Other)
Statistical approach: Estimated model parameter
Population: Unspecified, sex: Unspecified, ages  to 
Country: Colombia
Setting: Unspecified, Unspecified
Study period: 2015 - 2016
Parameter: Attack rate (Attack rate)
Value:  Percentage (%) (Median)
Exponent (base 10): 0
Bounds: 1 - 43
Statistical approach: Estimated model parameter
Disaggregated by: Region
Population: Persons under investigation, sex: , ages  to 
Country: Multi-country: Central and South America (n = 8)
Setting: Hospital based, 
Study period: Jan 2014 - 1 Feb 2016
Parameter: Attack rate (Attack rate)
Value:  Percentage (%) (Median)
Exponent (base 10): 0
Bounds: 5 - 49
Statistical approach: Estimated model parameter
Disaggregated by: Region
Population: Persons under investigation, sex: , ages  to 
Country: Multi-country: Central and South America (n = 8)
Setting: Hospital based, 
Study period: 1 Feb 2016 - 28 Feb 2017
Parameter: Seroprevalence - NS1 BOB ELISA (Seroprevalence)
Value: 36.1 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 34.5 - 37.8 (95% CI)
Bounds: 22 - 58
Seroprevalence adjustment: Naive
Statistical approach: Estimated model parameter
Disaggregated by: Age, Other, Region, Sex
Population: Children, sex: Both, ages 2 to 14
Country: Nicaragua
Location: District II, Managua
Setting: Household based, Unspecified
Study period: Feb 2017 - Jul 2017
Parameter: Seroprevalence - NS1 BOB ELISA (Seroprevalence)
Value: 45.8 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 43.4 - 48.3 (95% CI)
Seroprevalence adjustment: Naive
Statistical approach: Estimated model parameter
Disaggregated by: Age, Sex
Population: General population, sex: Both, ages 2 to 80
Country: Nicaragua
Location: District II, Managua
Setting: Household based, Unspecified
Study period: Feb 2017 - Jul 2017
Parameter: Seroprevalence - NS1 BOB ELISA (Seroprevalence)
Value: 56.4 Percentage (%) (Central)
Exponent (base 10): 0
Uncertainty: 53.1 - 59.6 (95% CI)
Bounds: 25 - 79.7
Seroprevalence adjustment: Naive
Statistical approach: Estimated model parameter
Disaggregated by: Age, Other, Region, Sex
Population: Other, sex: Both, ages 15 to 80
Country: Nicaragua
Location: District II, Managua
Setting: Household based, Unspecified
Study period: Feb 2017 - Jul 2017
Parameter: Mutations - evolutionary rate (Mutations)
Value:  Substitutions/site/year (Other)
Exponent (base 10): -3
Bounds: 0.53 - 4.39
Statistical approach: Estimated model parameter
Disaggregated by: Other
Genome site: Whole genome sequence
Country: Multi-country: Americas (n = 9), Asia (n = 5), Oceania (n = 1), Africa (n = 5), Europe (n = 1)
Sample size: 58
Study period: 1947 - 2016
Parameter: Reproduction number (Basic R0) - Vector-borne (Reproduction number)
Value: 4.2743 No units (Mean)
Exponent (base 10): 0
Uncertainty: 0.1663 - 12.9415 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: El Salvador
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.2055 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.4664 - 3.1658 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Human-human
Population: Persons under investigation, sex: , ages  to 
Country: El Salvador
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 2.4225 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.6526 - 3.4704 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Human-human
Population: Persons under investigation, sex: , ages  to 
Country: Suriname
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Reproduction number (Basic R0) - Sexual (Reproduction number)
Value: 2.4588 No units (Mean)
Exponent (base 10): 0
Uncertainty: 0.1519 - 7.4016 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: El Salvador
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Reproduction number (Basic R0) - Sexual (Reproduction number)
Value: 1.6667 No units (Mean)
Exponent (base 10): 0
Uncertainty: 0.1473 - 4.8498 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Suriname
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Reproduction number (Basic R0) - Vector-borne (Reproduction number)
Value: 6.0925 No units (Mean)
Exponent (base 10): 0
Uncertainty: 0.6002 - 15.7379 (95% CrI)
Statistical approach: Estimated model parameter
Reproduction number method: Next generation matrix Vector-human
Population: Persons under investigation, sex: , ages  to 
Country: Suriname
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Human delay - incubation period (Human delay)
Value: 5.5626 Days (Mean)
Exponent (base 10): 0
Uncertainty: 2.0001 - 15.5402 (95% CrI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: , ages  to 
Country: El Salvador
Setting: Population based, 
Sample size: 11825
Study period: 2015 - 22 Jun 2016
Parameter: Human delay - incubation period (Human delay)
Value: 6.6144 Days (Mean)
Exponent (base 10): 0
Uncertainty: 2.0001 - 16.8145 (95% CrI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: , ages  to 
Country: Suriname
Setting: Population based, 
Sample size: 3042
Study period: 2015 - 22 Jun 2016
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 8.4171 Days (Mean)
Exponent (base 10): 0
Uncertainty: 4.0001 - 17.0355 (95% CrI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: , ages  to 
Country: El Salvador
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Mosquito delay - extrinsic incubation period (Mosquito)
Value: 8.3111 Days (Mean)
Exponent (base 10): 0
Uncertainty: 4 - 16.9617 (95% CrI)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: , ages  to 
Country: Suriname
Setting: Population based, 
Study period: 2015 - 22 Jun 2016
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 0 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 0 / 215 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 18 to 75
Country: Sweden
Location: Gothenburg
Setting: Population based, Unspecified
Sample size: 215
Study period: 2015
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 1.4 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 12 / 874 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 17 to 62
Country: Rwanda
Location: 4 provinces and Kigali
Setting: Population based, Unspecified
Sample size: 874
Study period: 2015
Parameter: Human delay - Onset to Return to area with active vectors (Human delay)
Value: 2 Days (Median)
Exponent (base 10): 0
Uncertainty: -7 - 10 (Range)
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mainland, travel-related
Setting: Population based, 
Sample size: 625
Study period: 1 Jan 2016 - 15 Jul 2016
Parameter: Human delay - Onset to Implementation of vector control measures (Human delay)
Value: 13 Days (Median)
Exponent (base 10): 0
Uncertainty: 4 - 58 (Range)
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mainland, travel-related
Setting: Population based, 
Sample size: 625
Study period: 1 Jan 2016 - 15 Jul 2016
Parameter: Human delay - Reporting to Intervention (Human delay)
Value: 5 Days (Median)
Exponent (base 10): 0
Uncertainty: 2 - 38 (Range)
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: France
Location: Mainland, travel-related
Setting: Population based, 
Sample size: 625
Study period: 1 Jan 2016 - 15 Jul 2016
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Exponent (base 10): 0
Numerator/denominator: 16 / 969 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: United States
Location: Veterans Health Administration in US and Caribbean
Setting: Hospital based, 
Sample size: 183
Study period: 1 Dec 2015 - 31 Oct 2016
Parameter: Human delay - Admission to care to Discharge from care (Human delay)
Value: 6 Days (Median)
Exponent (base 10): 0
Uncertainty: 1 - 214 (Range)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Unspecified
Location: VA Caribbean Healthcare System
Setting: Hospital based, 
Sample size: 91
Study period: 1 Dec 2015 - 31 Oct 2016
Parameter: Human delay - Admission to Critical Care/ICU to Discharge from Critical Care/ICU (Human delay)
Value: 4 Days (Median)
Exponent (base 10): 0
Uncertainty: 1 - 30 (Range)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Unspecified
Location: VA Caribbean Healthcare System
Setting: Hospital based, 
Sample size: 20
Study period: 1 Dec 2015 - 31 Oct 2016
Parameter: Human delay - Admission to care to Discharge from care (Human delay)
Value: 4 Days (Median)
Exponent (base 10): 0
Uncertainty: 1 - 6 (Range)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Unspecified
Location: VA hospitals in US
Setting: Hospital based, 
Sample size: 3
Study period: 1 Dec 2015 - 31 Oct 2016
Parameter: Human delay - Diagnosis/test result to Death (Human delay)
Value: 39 Days (Median)
Exponent (base 10): 0
Uncertainty: 3 - 104 (Range)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Unspecified
Location: VA Caribbean Healthcare System
Setting: Hospital based, 
Sample size: 19
Study period: 1 Dec 2015 - 31 Oct 2016
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 9.1 Percentage (%) (Mean)
Exponent (base 10): 0
Uncertainty: 3.95 - 11.01 (95% CI)
Bounds: 0 - 18.2
Case definition: Confirmed
Numerator/denominator: 60 / 662 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Disaggregated by: Other, Region
Population: Children, sex: Unspecified, ages 1 to 4
Country: Indonesia
Location: Aceh, North Sumatra, West Sumatra, Jambi, Lampung, Banten, DKI Jakarta, West Java, Central Java, East Java, Bali, East Kalimantan, South Sulawesi, Southeast Sulawesi
Setting: Population based, Urban area
Sample size: 662
Study period: Oct 2014 - Nov 2014
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.89 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.21 - 2.13 (95% CI)
Bounds: 1.73 - 2.38
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Compartmental model Vector-human
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Colombia
Setting: Population based, Unspecified
Sample size: 18364
Study period: 2015 - 2016
Parameter: Reproduction number (Basic R0) - Sexual (Reproduction number)
Value: 0.42 No units (Mean)
Exponent (base 10): 0
Uncertainty: 0.29 - 0.64 (95% CI)
Bounds: 0.15 - 0.42
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Compartmental model Human-human
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Colombia
Setting: Population based, Unspecified
Sample size: 18364
Study period: 2015 - 2016
Parameter: Reproduction number (Basic R0) - Vector-borne (Reproduction number)
Value: 1.51 No units (Mean)
Exponent (base 10): 0
Uncertainty: 1.23 - 1.87 (95% CI)
Bounds: 1.51 - 2.02
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Compartmental model Animal-animal
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Colombia
Setting: Population based, Unspecified
Sample size: 18364
Study period: 2015 - 2016
Parameter: Relative contribution - sexual (Relative contribution)
Value: 15.36 Percentage (%) (Mean)
Exponent (base 10): 0
Uncertainty: 12.83 - 17.14 (95% CI)
Bounds: 5.31 - 15.36
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Compartmental model Human-human
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Colombia
Setting: Population based, Unspecified
Sample size: 18364
Study period: 2015 - 2016
Parameter: Human delay - Onset of antecedent symptoms to Onset of neurologic symptoms (Human delay)
Value: 6 Days (Median)
Exponent (base 10): 0
Uncertainty: 0 - 55 (Range)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Colombia
Location: Barranquilla
Setting: Hospital based, Unspecified
Sample size: 47
Study period: 1 Oct 2015 - 2 Apr 2016
Parameter: Human delay - Onset of neurologic symptoms to Admission to care (Human delay)
Value: 9 Days (Median)
Exponent (base 10): 0
Uncertainty: 0 - 56 (Range)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Colombia
Location: Barranquilla
Setting: Hospital based, Unspecified
Sample size: 47
Study period: 1 Oct 2015 - 2 Apr 2016
Parameter: Human delay - Admission to care to Discharge from care (Human delay)
Value: 22 Days (Median)
Exponent (base 10): 0
Uncertainty: 3 - 102 (Range)
Statistical approach: Observed sample statistic
Population: Other, sex: Both, ages  to 
Country: Colombia
Location: Barranquilla
Setting: Hospital based, Unspecified
Sample size: 47
Study period: 1 Oct 2015 - 2 Apr 2016
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 30.9 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 26.3 - 35.9 (95% CI)
Numerator/denominator: 112 / 362 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Household contacts of survivors, sex: Both, ages  to 
Country: United States
Location: Puerto Rico: Ponce, San Juan, Guayama
Setting: Household based, Unspecified
Sample size: 362
Study period: May 2016 - Jul 2017
Parameter: Human delay - Onset to Admission to care (Human delay)
Value: 4 Days (Median)
Exponent (base 10): 0
Uncertainty: 1 - 16 (IQR)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Both, ages 0 to 82
Country: Colombia
Location: San Andrés
Setting: Hospital based, Unspecified
Sample size: 928
Study period: 6 Sep 2015 - 30 Jan 2016
Parameter: Human delay - Onset to Admission to care (Human delay)
Value: 1 Days (Median)
Exponent (base 10): 0
Uncertainty: 1 - 2 (IQR)
Statistical approach: Estimated model parameter
Population: Persons under investigation, sex: Both, ages 0 to 92
Country: Colombia
Location: Girardot
Setting: Hospital based, Urban area
Sample size: 1936
Study period: 19 Oct 2015 - 22 Jan 2016
Parameter: Attack rate (Attack rate)
Value: 1.213 Percentage (%) (Unspecified)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: Persons under investigation, sex: Both, ages 0 to 82
Country: Colombia
Location: San Andrés
Setting: Hospital based, Unspecified
Sample size: 928
Study period: 6 Sep 2015 - 30 Jan 2016
Parameter: Attack rate (Attack rate)
Value: 1.843 Percentage (%) (Unspecified)
Exponent (base 10): 0
Statistical approach: Observed sample statistic
Disaggregated by: Age, Sex
Population: Persons under investigation, sex: Both, ages 0 to 92
Country: Colombia
Location: Girardot
Setting: Hospital based, Urban area
Sample size: 1936
Study period: 19 Oct 2015 - 22 Jan 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.41 No units ()
Exponent (base 10): 0
Uncertainty: 1.15 - 1.74 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Human-human
Population: Persons under investigation, sex: Both, ages 0 to 82
Country: Colombia
Location: San Andrés
Setting: Hospital based, Unspecified
Sample size: 928
Study period: 6 Sep 2015 - 30 Jan 2016
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 4.61 No units ()
Exponent (base 10): 0
Uncertainty: 4.11 - 5.16 (95% CI)
Statistical approach: Estimated model parameter
Reproduction number method: Other Human-human
Population: Persons under investigation, sex: Both, ages 0 to 92
Country: Colombia
Location: Girardot
Setting: Hospital based, Urban area
Sample size: 1936
Study period: 19 Oct 2015 - 22 Jan 2016
Parameter: Attack rate (Attack rate)
Value: 73 Percentage (%) (Unspecified)
Exponent (base 10): 0
Uncertainty: 70 - 76 (95% CI)
Bounds: 29 - 83
Statistical approach: Estimated model parameter
Disaggregated by: Region
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Sample size: 1453
Study period: 2015
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.8 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 1.7 - 1.9 (95% CI)
Bounds: 1.2 - 2.1
Statistical approach: Estimated model parameter
Disaggregated by: Region
Reproduction number method: Other Human-human
Population: General population, sex: Both, ages  to 
Country: Brazil
Location: Salvador, Bahia
Setting: Population based, Urban area
Sample size: 1453
Study period: 2015